Sisram Medical, a Fosun Pharma subsidiary, has reported a significant increase in demand for aesthetic medical treatments across China. The company’s CEO stated that the growing segment of young consumers, particularly men, is prioritizing self-care and wellness. This trend reflects a broader shift in Asian priorities, with Asia representing a particularly lucrative market opportunity compared to established regions like North America. Alma, a Sisram Medical division, anticipates continued growth within this sector driven by the increasing popularity of laser therapies for physical and emotional wellbeing. The company attributes this to a desire for improved quality of life and enhanced self-image.
Credits: News – South China Morning Post
